Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

New report shows an increase in HIV cases in Alberta. Experts tell Hiba Kamal-Choufi there should be a holistic approach to ...

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

While annual HIV surveillance reports released by the CDC in May showed that the number of estimated new HIV infections per ...

The Centers for Disease Control and Prevention provides funding for HIV prevention for the populations at the highest risk of ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...